<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32020025</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>04</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The upper cervical spinal cord in ALS assessed by cross-sectional and longitudinal 3T MRI.</ArticleTitle><Pagination><StartPage>1783</StartPage><MedlinePgn>1783</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1783</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-58687-z</ELocationID><Abstract><AbstractText>The upper cervical spinal cord is measured in a large longitudinal amyotrophic lateral sclerosis (ALS) cohort to evaluate its role as a biomarker. Specifically, the cervical spinal cord&#xb4;s cross-sectional area (CSA) in plane of the segments C1-C3 was measured semi-automatically with T1-weighted 3T MRI sequences in 158 ALS patients and 86 controls. Six-month longitudinal follow-up MRI scans were analyzed in 103 patients. Compared to controls, in ALS there was a significant mean spinal cord atrophy (63.8&#x2009;mm&#xb2; vs. 60.8&#x2009;mm&#xb2;, p&#x2009;=&#x2009;0.001) which showed a trend towards worsening over time (mean spinal cord CSA decrease from 61.4&#x2009;mm&#xb2; to 60.6&#x2009;mm&#xb2; after 6 months, p&#x2009;=&#x2009;0.06). Findings were most pronounced in the caudal segments of the upper cervical spinal cord and in limb-onset ALS. Baseline CSA was related to the revised ALS functional rating scale, disease duration, precentral gyrus thickness and total brain gray matter volume. In conclusion, spinal cord atrophy as assessed in brain MRIs in ALS patients mirrors the extent of overall neurodegeneration and parallels disease severity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wimmer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9938-7927</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schreiber</LastName><ForeName>Frank</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-9484-8613</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Magdeburg Site, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hensiek</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garz</LastName><ForeName>Cornelia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Magdeburg Site, Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leibniz Institute for Neurobiology (LIN), Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufmann</LastName><ForeName>J&#xf6;rn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machts</LastName><ForeName>Judith</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8660-095X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Magdeburg Site, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vogt</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4238-3516</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prudlo</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical School Rostock, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Rostock Site, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dengler</LastName><ForeName>Reinhard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3715-6100</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petri</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9783-8584</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heinze</LastName><ForeName>Hans-Jochen</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Magdeburg Site, Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Leibniz Institute for Neurobiology (LIN), Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nestor</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-5860-5921</Identifier><AffiliationInfo><Affiliation>Queensland Brain Institute, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mater Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vielhaber</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Magdeburg Site, Magdeburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schreiber</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4439-4374</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany. stefanie.schreiber@med.ovgu.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases, Magdeburg Site, Magdeburg, Germany. stefanie.schreiber@med.ovgu.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany. stefanie.schreiber@med.ovgu.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066193" MajorTopicYN="N">Cervical Cord</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32020025</ArticleId><ArticleId IdType="pmc">PMC7000761</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-58687-z</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-58687-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goetz Christopher G. Amyotrophic lateral sclerosis: Early contributions of Jean-Martin Charcot. Muscle &amp; Nerve. 2000;23(3):336&#x2013;343. doi: 10.1002/(SICI)1097-4598(200003)23:3&lt;336::AID-MUS4&gt;3.0.CO;2-L.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(200003)23:3&lt;336::AID-MUS4&gt;3.0.CO;2-L</ArticleId><ArticleId IdType="pubmed">10679709</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, et al. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 2014;128:423&#x2013;437. doi: 10.1007/s00401-014-1299-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1299-6</ArticleId><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F, et al. Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy. Acta Neuropathol. 2011;121:509&#x2013;517. doi: 10.1007/s00401-011-0797-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0797-z</ArticleId><ArticleId IdType="pmc">PMC3125638</ArticleId><ArticleId IdType="pubmed">21225272</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, et al. A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2009;80:53&#x2013;55. doi: 10.1136/jnnp.2008.154252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.154252</ArticleId><ArticleId IdType="pubmed">18931009</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Adad J, et al. Involvement of spinal sensory pathway in ALS and specificity of cord atrophy to lower motor neuron degeneration. Amyotrophic lateral sclerosis &amp; frontotemporal degeneration. 2013;14:30&#x2013;38. doi: 10.3109/17482968.2012.701308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.701308</ArticleId><ArticleId IdType="pubmed">22881412</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Adad J, et al. 7-T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis. Muscle Nerve. 2013;47:760&#x2013;762. doi: 10.1002/mus.23720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.23720</ArticleId><ArticleId IdType="pubmed">23553571</ArticleId></ArticleIdList></Reference><Reference><Citation>Branco LMT, et al. Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis. Amyotroph Lat. Scl. Fr. 2014;15:93&#x2013;97. doi: 10.3109/21678421.2013.852589.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.852589</ArticleId><ArticleId IdType="pubmed">24219347</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquin M-&#xca;, et al. Spinal Cord Gray Matter Atrophy in Amyotrophic Lateral Sclerosis. AJNR. American journal of neuroradiology. 2018;39:184&#x2013;192. doi: 10.3174/ajnr.A5427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5427</ArticleId><ArticleId IdType="pmc">PMC7410702</ArticleId><ArticleId IdType="pubmed">29122760</ArticleId></ArticleIdList></Reference><Reference><Citation>Valsasina P, et al. Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2007;78:480&#x2013;484. doi: 10.1136/jnnp.2006.100032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.100032</ArticleId><ArticleId IdType="pmc">PMC2117814</ArticleId><ArticleId IdType="pubmed">17030586</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney NT, et al. Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease. PLoS One. 2018;13:e0208255. doi: 10.1371/journal.pone.0208255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208255</ArticleId><ArticleId IdType="pmc">PMC6264489</ArticleId><ArticleId IdType="pubmed">30496320</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili MM, et al. Multi-parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis. PLoS One. 2014;9:e95516. doi: 10.1371/journal.pone.0095516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095516</ArticleId><ArticleId IdType="pmc">PMC3995720</ArticleId><ArticleId IdType="pubmed">24755826</ArticleId></ArticleIdList></Reference><Reference><Citation>Albuquerque M, et al. Longitudinal evaluation of cerebral and spinal cord damage in Amyotrophic Lateral Sclerosis. Neuroimage Clin. 2017;14:269&#x2013;276. doi: 10.1016/j.nicl.2017.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.01.024</ArticleId><ArticleId IdType="pmc">PMC5294732</ArticleId><ArticleId IdType="pubmed">28203530</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited. Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sc. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks Benjamin Rix. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 1994;124:96&#x2013;107. doi: 10.1016/0022-510X(94)90191-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90191-0</ArticleId><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho M, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497&#x2013;503. doi: 10.1016/j.clinph.2007.09.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber S, et al. Peripheral nerve ultrasound in amyotrophic lateral sclerosis phenotypes. Muscle Nerve. 2015;51:669&#x2013;675. doi: 10.1002/mus.24431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24431</ArticleId><ArticleId IdType="pubmed">25155020</ArticleId></ArticleIdList></Reference><Reference><Citation>van den RM B-V, et al. The spectrum of lower motor neuron syndromes. J Neurol. 2003;250:1279&#x2013;1292. doi: 10.1007/s00415-003-0235-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-003-0235-9</ArticleId><ArticleId IdType="pubmed">14648143</ArticleId></ArticleIdList></Reference><Reference><Citation>van den RM B-V, et al. Sporadic lower motor neuron disease with adult onset. Classification of subtypes. Brain. 2003;126:1036&#x2013;1047. doi: 10.1093/brain/awg117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awg117</ArticleId><ArticleId IdType="pubmed">12690044</ArticleId></ArticleIdList></Reference><Reference><Citation>Soraru G, et al. Natural history of upper motor neuron-dominant ALS. Amyotroph. Lateral. Scler. 2010;11:424&#x2013;429. doi: 10.3109/17482960903300867.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903300867</ArticleId><ArticleId IdType="pubmed">19929748</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology. 2009;72:1948&#x2013;1952. doi: 10.1212/WNL.0b013e3181a8269b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181a8269b</ArticleId><ArticleId IdType="pubmed">19487653</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, et al. Amyotrophic lateral sclerosis: moving towards a new classification system. The Lancet Neurology. 2016;15:1182&#x2013;1194. doi: 10.1016/S1474-4422(16)30199-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30199-5</ArticleId><ArticleId IdType="pubmed">27647646</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Chipika RH, Shing SLH, Hardiman O, Bede P. Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotrophic lateral sclerosis &amp; frontotemporal degeneration. 2019;20:133&#x2013;145. doi: 10.1080/21678421.2018.1550518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1550518</ArticleId><ArticleId IdType="pubmed">30654671</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, et al. The natural history of primary lateral sclerosis. Neurology. 2006;66:647&#x2013;653. doi: 10.1212/01.wnl.0000200962.94777.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000200962.94777.71</ArticleId><ArticleId IdType="pubmed">16534101</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartaglia MC, et al. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis. Examination of symptoms and signs at disease onset and during follow-up. Arch. Neurol. 2007;64:232&#x2013;236. doi: 10.1001/archneur.64.2.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.64.2.232</ArticleId><ArticleId IdType="pubmed">17296839</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456&#x2013;2477. doi: 10.1093/brain/awr179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T, et al. Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation? J Neurol Neurosurg Psychiatry. 2016;87:1022&#x2013;1026. doi: 10.1136/jnnp-2015-312185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-312185</ArticleId><ArticleId IdType="pmc">PMC5013137</ArticleId><ArticleId IdType="pubmed">27010615</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2013;revised report of an EFNS task force. Eur J. Neurol. 2012;19:360&#x2013;375. doi: 10.1111/j.1468-1331.2011.03501.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts J, et al. Basal ganglia pathology in ALS is associated with neuropsychological deficits. Neurology. 2015;85:1301&#x2013;1309. doi: 10.1212/WNL.0000000000002017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002017</ArticleId><ArticleId IdType="pubmed">26385880</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber S, et al. Significance of CSF NfL and tau in ALS. J Neurol. 2018;265:2633&#x2013;2645. doi: 10.1007/s00415-018-9043-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-9043-0</ArticleId><ArticleId IdType="pubmed">30187162</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergo, F. P. G., Fran&#xe7;a, M. C., Chevis, C. F. &amp; Cendes, F. SpineSeg: A segmentation and measurement tool for evaluation of spinal cord atrophy. 7th Iberian Conference on Information Systems and Technologies (CISTI 2012) pp. 1&#x2013;4 (2012).</Citation></Reference><Reference><Citation>Bergo FPG, Falc&#xe3;o AX, Miranda PAV, Rocha LM. Automatic Image Segmentation by Tree Pruning. Journal of Mathematical Imaging and Vision. 2007;29:141&#x2013;162. doi: 10.1007/s10851-007-0035-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10851-007-0035-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B, et al. Whole Brain Segmentation. Neuron. 2002;33:341&#x2013;355. doi: 10.1016/S0896-6273(02)00569-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00569-X</ArticleId><ArticleId IdType="pubmed">11832223</ArticleId></ArticleIdList></Reference><Reference><Citation>Kameyama T, Hashizume Y, Sobue G. Morphologic features of the normal human cadaveric spinal cord. Spine. 1996;21:1285&#x2013;1290. doi: 10.1097/00007632-199606010-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007632-199606010-00001</ArticleId><ArticleId IdType="pubmed">8725917</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, et al. The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. J. Neurol. Sci. 2010;294:81&#x2013;85. doi: 10.1016/j.jns.2010.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.03.028</ArticleId><ArticleId IdType="pubmed">20452624</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperfeld A-D, et al. MR-pathologic comparison of the upper spinal cord in different motor neuron diseases. Eur. Neurol. 2005;53:74&#x2013;77. doi: 10.1159/000084650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000084650</ArticleId><ArticleId IdType="pubmed">15785072</ArticleId></ArticleIdList></Reference><Reference><Citation>Losseff NA, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain. 1996;119(Pt 3):701&#x2013;708. doi: 10.1093/brain/119.3.701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/119.3.701</ArticleId><ArticleId IdType="pubmed">8673483</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>